Alkem Launches NeuCeno (Cenobamate) Treatment of Partial-onset Seizures in Adult Patients
Alkem launches NeuCeno (cenobamate) in India for partial-onset seizures in adults, marking the first introduction of cenobamate in the country.
Partial-onset Seizures | 16/09/2026 | By News Bureau
Lupin Limited Secures US FDA Approval for Generic Brivaracetam Oral Solution
Lupin has received US FDA approval for its generic brivaracetam oral solution, bioequivalent to Briviact, and has launched the product in the US market targeting partial-onset seizures.
Partial-onset Seizures | 25/02/2026 | By News Bureau | 365
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy